The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erectile Dysfunction Drugs Market Research Report 2025
Synopsis
The global market for Erectile Dysfunction Drugs was valued at US$ 5450 million in the year 2024 and is projected to reach a revised size of US$ 8149 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Erectile Dysfunction Drugs was valued at US$ 5450 million in the year 2024 and is projected to reach a revised size of US$ 8149 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Erectile Dysfunction Drugs Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction Drugs by Type
1.2.1 Global Erectile Dysfunction Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs by Application
1.3.1 Global Erectile Dysfunction Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Drugs Revenue 2020-2031
1.4.2 Global Erectile Dysfunction Drugs Sales 2020-2031
1.4.3 Global Erectile Dysfunction Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
2.7 Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
2.8 Global Erectile Dysfunction Drugs Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erectile Dysfunction Drugs Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Drugs Market Scenario by Region
3.1 Global Erectile Dysfunction Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erectile Dysfunction Drugs Sales by Region: 2020-2031
3.2.1 Global Erectile Dysfunction Drugs Sales by Region: 2020-2025
3.2.2 Global Erectile Dysfunction Drugs Sales by Region: 2026-2031
3.3 Global Erectile Dysfunction Drugs Revenue by Region: 2020-2031
3.3.1 Global Erectile Dysfunction Drugs Revenue by Region: 2020-2025
3.3.2 Global Erectile Dysfunction Drugs Revenue by Region: 2026-2031
3.4 North America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.4.3 North America Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.5.3 Europe Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erectile Dysfunction Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.7.3 Latin America Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2031)
4.1.1 Global Erectile Dysfunction Drugs Sales by Type (2020-2025)
4.1.2 Global Erectile Dysfunction Drugs Sales by Type (2026-2031)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2020-2031)
4.2 Global Erectile Dysfunction Drugs Revenue by Type (2020-2031)
4.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2020-2025)
4.2.2 Global Erectile Dysfunction Drugs Revenue by Type (2026-2031)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Erectile Dysfunction Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application (2020-2031)
5.1.1 Global Erectile Dysfunction Drugs Sales by Application (2020-2025)
5.1.2 Global Erectile Dysfunction Drugs Sales by Application (2026-2031)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2020-2031)
5.2 Global Erectile Dysfunction Drugs Revenue by Application (2020-2031)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2020-2025)
5.2.2 Global Erectile Dysfunction Drugs Revenue by Application (2026-2031)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Erectile Dysfunction Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Company Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Company Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Company Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.7.1 Dong-A ST Company Information
6.7.2 Dong-A ST Description and Business Overview
6.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Company Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Company Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Company Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Drugs Industry Chain Analysis
7.2 Erectile Dysfunction Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Drugs Production Mode & Process Analysis
7.4 Erectile Dysfunction Drugs Sales and Marketing
7.4.1 Erectile Dysfunction Drugs Sales Channels
7.4.2 Erectile Dysfunction Drugs Distributors
7.5 Erectile Dysfunction Drugs Customer Analysis
8 Erectile Dysfunction Drugs Market Dynamics
8.1 Erectile Dysfunction Drugs Industry Trends
8.2 Erectile Dysfunction Drugs Market Drivers
8.3 Erectile Dysfunction Drugs Market Challenges
8.4 Erectile Dysfunction Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Erectile Dysfunction Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Erectile Dysfunction Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Erectile Dysfunction Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Erectile Dysfunction Drugs Sales (M Pill) of Key Manufacturers (2020-2025)
Table 5. Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Erectile Dysfunction Drugs Average Price (USD/Pill) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Erectile Dysfunction Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Erectile Dysfunction Drugs Sales by Region (2020-2025) & (M Pill)
Table 18. Global Erectile Dysfunction Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Erectile Dysfunction Drugs Sales by Region (2026-2031) & (M Pill)
Table 20. Global Erectile Dysfunction Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Erectile Dysfunction Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Erectile Dysfunction Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Erectile Dysfunction Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Erectile Dysfunction Drugs Sales by Country (2020-2025) & (M Pill)
Table 27. North America Erectile Dysfunction Drugs Sales by Country (2026-2031) & (M Pill)
Table 28. North America Erectile Dysfunction Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Erectile Dysfunction Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Erectile Dysfunction Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Erectile Dysfunction Drugs Sales by Country (2020-2025) & (M Pill)
Table 32. Europe Erectile Dysfunction Drugs Sales by Country (2026-2031) & (M Pill)
Table 33. Europe Erectile Dysfunction Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Erectile Dysfunction Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Erectile Dysfunction Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2020-2025) & (M Pill)
Table 37. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2026-2031) & (M Pill)
Table 38. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Erectile Dysfunction Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Erectile Dysfunction Drugs Sales by Country (2020-2025) & (M Pill)
Table 42. Latin America Erectile Dysfunction Drugs Sales by Country (2026-2031) & (M Pill)
Table 43. Latin America Erectile Dysfunction Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Erectile Dysfunction Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2020-2025) & (M Pill)
Table 47. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2026-2031) & (M Pill)
Table 48. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2020-2025)
Table 51. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2026-2031)
Table 52. Global Erectile Dysfunction Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Erectile Dysfunction Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2020-2025)
Table 59. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2026-2031)
Table 60. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2020-2025)
Table 61. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2026-2031)
Table 62. Global Erectile Dysfunction Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Erectile Dysfunction Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2020-2025)
Table 69. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2026-2031)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 73. Eli Lilly Erectile Dysfunction Drugs Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 78. Pfizer Erectile Dysfunction Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 83. Bayer Erectile Dysfunction Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. BaiYunShan General Factory Company Information
Table 86. BaiYunShan General Factory Description and Business Overview
Table 87. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 88. BaiYunShan General Factory Erectile Dysfunction Drugs Product
Table 89. BaiYunShan General Factory Recent Developments/Updates
Table 90. S.K. Chemicals Company Information
Table 91. S.K. Chemicals Description and Business Overview
Table 92. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 93. S.K. Chemicals Erectile Dysfunction Drugs Product
Table 94. S.K. Chemicals Recent Developments/Updates
Table 95. Teva Pharma Company Information
Table 96. Teva Pharma Description and Business Overview
Table 97. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 98. Teva Pharma Erectile Dysfunction Drugs Product
Table 99. Teva Pharma Recent Developments/Updates
Table 100. Dong-A ST Company Information
Table 101. Dong-A ST Description and Business Overview
Table 102. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 103. Dong-A ST Erectile Dysfunction Drugs Product
Table 104. Dong-A ST Recent Developments/Updates
Table 105. Metuchen Pharma Company Information
Table 106. Metuchen Pharma Description and Business Overview
Table 107. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 108. Metuchen Pharma Erectile Dysfunction Drugs Product
Table 109. Metuchen Pharma Recent Developments/Updates
Table 110. Seoul Pharma Company Information
Table 111. Seoul Pharma Description and Business Overview
Table 112. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 113. Seoul Pharma Erectile Dysfunction Drugs Product
Table 114. Seoul Pharma Recent Developments/Updates
Table 115. CSBIO. Company Information
Table 116. CSBIO. Description and Business Overview
Table 117. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2020-2025)
Table 118. CSBIO. Erectile Dysfunction Drugs Product
Table 119. CSBIO. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Erectile Dysfunction Drugs Distributors List
Table 123. Erectile Dysfunction Drugs Customers List
Table 124. Erectile Dysfunction Drugs Market Trends
Table 125. Erectile Dysfunction Drugs Market Drivers
Table 126. Erectile Dysfunction Drugs Market Challenges
Table 127. Erectile Dysfunction Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Erectile Dysfunction Drugs
Figure 2. Global Erectile Dysfunction Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Erectile Dysfunction Drugs Market Share by Type: 2024 & 2031
Figure 4. Sildenafil Product Picture
Figure 5. Tadalafil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erectile Dysfunction Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Erectile Dysfunction Drugs Market Share by Application: 2024 & 2031
Figure 9. Hospital Pharmacies
Figure 10. Private Clinics
Figure 11. Retail Pharmacies
Figure 12. E-Commerce (B2B)
Figure 13. E-Commerce (B2C)
Figure 14. Global Erectile Dysfunction Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Erectile Dysfunction Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Erectile Dysfunction Drugs Sales (2020-2031) & (M Pill)
Figure 17. Global Erectile Dysfunction Drugs Average Price (USD/Pill) & (2020-2031)
Figure 18. Erectile Dysfunction Drugs Report Years Considered
Figure 19. Erectile Dysfunction Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Erectile Dysfunction Drugs Players: Market Share by Revenue in Erectile Dysfunction Drugs in 2024
Figure 22. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Erectile Dysfunction Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Erectile Dysfunction Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Erectile Dysfunction Drugs Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Erectile Dysfunction Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Erectile Dysfunction Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Erectile Dysfunction Drugs Sales Market Share by Country (2020-2031)
Figure 47. Latin America Erectile Dysfunction Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Erectile Dysfunction Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Erectile Dysfunction Drugs by Type (2020-2031)
Figure 57. Global Revenue Market Share of Erectile Dysfunction Drugs by Type (2020-2031)
Figure 58. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2020-2031)
Figure 59. Global Sales Market Share of Erectile Dysfunction Drugs by Application (2020-2031)
Figure 60. Global Revenue Market Share of Erectile Dysfunction Drugs by Application (2020-2031)
Figure 61. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2020-2031)
Figure 62. Erectile Dysfunction Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
